Ishares Medical Devices Etf Profile
| IHI Etf | USD 61.11 0.16 0.26% |
Performance6 of 100
| Odds Of DistressLess than 9
|
IShares Medical is trading at 61.11 as of the 30th of November 2024. This is a 0.26 percent increase since the beginning of the trading day. The etf's open price was 60.95. IShares Medical has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for iShares Medical Devices are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
The fund will invest at least 80 percent of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. More on iShares Medical Devices
Moving against IShares Etf
IShares Etf Highlights
| Chairman | George Parker |
| Thematic Ideas | (View all Themes) |
| Business Concentration | Sector ETFs, Health Care ETFs, Health, iShares (View all Sectors) |
| Issuer | iShares |
| Inception Date | 2006-05-01 |
| Benchmark | Dow Jones U.S. Select Medical Equipment Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 4.76 Billion |
| Average Trading Valume | 594,228.8 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
| Region | North America |
| Administrator | Citibank, N.A. |
| Advisor | BlackRock Fund Advisors |
| Custodian | Citibank, N.A. |
| Distributor | BlackRock Investments, LLC |
| Portfolio Manager | Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason |
| Transfer Agent | Citibank, N.A. |
| Fiscal Year End | 31-Mar |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 53.0 |
| Market Maker | Latour Trading |
| Total Expense | 0.4 |
| Management Fee | 0.4 |
| Country Name | USA |
| Returns Y T D | 13.26 |
| Name | iShares U.S. Medical Devices ETF |
| Currency Code | USD |
| Open Figi | BBG000P9YC26 |
| In Threey Volatility | 19.64 |
| 1y Volatility | 16.19 |
| 200 Day M A | 57.2968 |
| 50 Day M A | 59.2854 |
| Code | IHI |
| Updated At | 30th of November 2024 |
| Currency Name | US Dollar |
iShares Medical Devices [IHI] is traded in USA and was established 2006-05-01. The fund is classified under Health category within iShares family. The entity is thematically classified as Sector ETFs. iShares Medical Devices currently have 5.79 B in assets under management (AUM). , while the total return for the last 3 years was -0.6%.
Check IShares Medical Probability Of Bankruptcy
Geographic Allocation (%)
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on IShares Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding IShares Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as iShares Medical Devices Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top iShares Medical Devices Etf Constituents
| ABT | Abbott Laboratories | Stock | Health Care | |
| BAX | Baxter International | Stock | Health Care | |
| BDX | Becton Dickinson and | Stock | Health Care | |
| BSX | Boston Scientific Corp | Stock | Health Care | |
| DHR | Danaher | Stock | Health Care | |
| EW | Edwards Lifesciences Corp | Stock | Health Care | |
| IDXX | IDEXX Laboratories | Stock | Health Care | |
| ISRG | Intuitive Surgical | Stock | Health Care |
IShares Medical Top Holders
| BRAPX | Blackrock Aggressive Gwthprprdptfinvstrr | Mutual Fund | Allocation--70% to 85% Equity | |
| BKGPX | Blackrock 6040 Target | Mutual Fund | Allocation--50% to 70% Equity | |
| BAAPX | Blackrock Aggressive Gwthprprdptfinvstra | Mutual Fund | Allocation--70% to 85% Equity | |
| BKAPX | Blackrock 8020 Target | Mutual Fund | Allocation--70% to 85% Equity | |
| BCAPX | Blackrock Aggressive Prprd | Mutual Fund | Allocation--70% to 85% Equity | |
| BIGPX | Blackrock Gwth Ptf | Mutual Fund | Allocation--50% to 70% Equity | |
| BRGPX | Blackrock Gwth Prepared | Mutual Fund | Allocation--50% to 70% Equity | |
| BAGPX | Blackrock Gwth Ptf | Mutual Fund | Allocation--50% to 70% Equity |
iShares Medical Devices Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | 0.0767 | |||
| Jensen Alpha | 0.0046 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | (0.09) |
IShares Medical Against Markets
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Medical Devices. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
The market value of iShares Medical Devices is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Medical's value that differs from its market value or its book value, called intrinsic value, which is IShares Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Medical's market value can be influenced by many factors that don't directly affect IShares Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.